
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles.
Is XLV's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Something unusual happened in October: the parts of the market farthest from AI surged while megacap tech stalled, and now a record-breaking gap is sitting right in the path of the biggest earnings week of the year.

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.

State Street Health Care Select Sector SPDR ETF focuses exclusively on S&P 500 healthcare components, leading to a highly concentrated portfolio. Fidelity MSCI Health Care Index ETF provides broader industry exposure and reaches deeper into mid-cap and small-cap segments.

U.S. equities have seen a sharp divide in sector performance in 2026, with geopolitical tensions and artificial intelligence (AI) investment influencing returns.

Healthcare ETFs are hovering near 52-week highs as earnings prospects improve, clinical breakthroughs advance and GLP-1 demand expands. Explore five ETFs riding the rally.